TeloVac Trial - Centres Taking Part

TeloVac is a UK based pancreatic trial. There are several centres currently open within the UK with the eventual aim of having around 70 centres participating.

The hospitals that are currently open are listed below. Sites which are open to Immunomonitoring and Future analysis are shown in brackets.

1. Aberdeen Royal Infirmary
2. Addenbrookes Hospital
3. Bristol Haematology and Oncology Centre,
4. Christie Hospital
5. Clatterbridge Centre for Oncology (Immunomonitoring & Future Analysis)
6. Conquest Hospital
7. Glan Clwyd Hospital
8. Guys & St Thomas Hospital
9. Huddersfield Royal Infirmary
10. Leicester Royal Infirmary
11. Newcastle General Hospital
12. Norfolk and Norwich University Hospital
13. North Hampshire NHS Trust
14. Peterborough District Hospital,
15. Poole Hospital NHS Trust
16. Portsmouth Oncology Centre
17. Royal Bournemouth Hospital
18. Royal Cornwall Hospital
19. Royal Devon and Exeter Hospital
20. Royal Free Hospital
21. Royal Liverpool University Hospital (Immunomonitoring & Future Analysis)
22. Royal Marsden Hospital (Immunomonitoring & Future Analysis)
23. Royal Marsden Hospital (Immunomonitoring & Future Analysis)
24. Southampton University Hospital
25. Royal Surrey County Hospital (Immunomonitoring & Future Analysis)
26. Salisbury District Hospital
27. St. Bartholomew's Hospital
28. Sussex Oncology Centre
29. Torbay District General Hospital
30. Beatson West of Scotland Oncology Centre
31. Weston Park Hospital
32. Wrexham Maelor Hospital
33. Yeovil District Hospital,
34. Middlesborough
35. Worthing Hospital
36. Mount Vernon Cancer Centre
37. Davent Valley Hospital
38. Ipswich Hospital
39. North Devon District Hospital
40. Wexham Park Hospital

The map below shows a rough guide to where sites will be opening within the UK. Open sites are shown as green dots on the map